Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0I1WN | ||||
| Former ID | DNC009976 | ||||
| Drug Name | 1,10-(methylenedi-4,1-phenylene)bismaleimide | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [530251] | ||
| Formula | C21H14N2O4 | ||||
| Canonical SMILES | C1=CC(=CC=C1CC2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O | ||||
| InChI | 1S/C21H14N2O4/c24-18-9-10-19(25)22(18)16-5-1-14(2-6-16)13-15-3-7-17(8-4-15)23-20(26)11-12-21(23)27/h1-12H,13H2 | ||||
| InChIKey | XQUPVDVFXZDTLT-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
